Idarucizumab for a traumatic head injury patient taking dabigatran

BACKGROUND: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who was trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Shuhei, Hayakawa, Koichi, Kanayama, Shuji, Iwamura, Hiromu, Wada, Daiki, Saito, Fukuki, Nakamori, Yasushi, Kuwagata, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326148/
https://www.ncbi.nlm.nih.gov/pubmed/31179930
http://dx.doi.org/10.1186/s12245-018-0202-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326148/
https://www.ncbi.nlm.nih.gov/pubmed/31179930
http://dx.doi.org/10.1186/s12245-018-0202-y

Ejemplares similares